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Abstract
Background: Ulcerative colitis (UC) is a chronic inflammatory disorder of still unknown pathogenesis. Increasing
evidence indicates that alterations in mitochondrial respiration and thus adenosine triphosphate (ATP) production
are involved. This may contribute to mucosal energy deficiency and subsequently intestinal barrier malfunction,
which is accepted to be a major hallmark of UC. Genetic alterations of the mitochondrial genome are one cause of
mitochondrial dysfunction. However, less is known about mitochondrial gene polymorphisms in UC. Therefore, we
aimed at identifying genetic associations between mitochondrial polymorphisms and UC.
Methods: German UC cases (n = 1062) and German healthy controls (n = 3030) were genotyped using the
Affymetrix Genome-Wide Human SNP Array 6.0. The primary association analysis was to test for associations
between mitochondrial single nucleotide polymorphisms (SNPs) and UC using Fisher’s exact test in the total sample
and stratified by sex. In addition, we tested for associations between mitochondrial haplogroups and UC and for
interactions between the most promising mitochondrial SNPs and nuclear SNPs. An independent set of German
subjects with 1625 UC cases and 3575 controls was used for replication.
Results: We identified a genetic association between the MT-ND4 11719 A/G polymorphism and UC in the subgroup
of males (rs2853495; odds ratio, 1.40; 95 % confidence interval, 1.13 to 1.73; p = 0.002). This association was replicated in
the second independent cohort. In the association analysis based on mitochondrial haplogroups the lowest p values
were reached for haplogroups HV and T (p = 0.029 and 0.035). Haplogroup HV is determined by the mitochondrial
11719 A/G polymorphism. Accordingly, this association was only found in the subgroup of males (p = 0.009).
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Conclusions: For the first time, we observed an association between the MT-ND4 11719 A/G polymorphism and UC.
The gene MT-ND4 encodes for a subunit of the mitochondrial electron transport chain complex I, which is pivotal for
ATP production and might therefore contribute to mucosal energy deficiency. The male-specific association indicates
differences between males and females concerning the impact of mitochondrial gene polymorphisms on the
development of UC. Further investigations of the functional mechanism underlying this association and the relevance
of the gender-specificity are highly warranted.
Keywords: Mitochondrial gene polymorphism, Ulcerative colitis, Male-specific association, Mucosal energy deficiency,
Mitochondria-wide association study, MT-ND4, rs2853495, ATP, Haplogroup HV
Background
Ulcerative colitis (UC) belongs to the family of inflam-
matory bowel diseases (IBD). In western countries, UC
exhibits rising prevalence with a slight predominance for
males [1]. UC is identified by chronic and recurrent in-
testinal inflammation of yet unknown origin. The
present pathophysiological concept suggests a disturbed
intestinal barrier due to a combination of factors, includ-
ing dysregulation of the host’s mucosal immune system,
environmental factors, changes in the intestinal micro-
biome and a genetic susceptibility [2–4]. Furthermore,
mucosal adenosine triphosphate (ATP) levels are re-
duced in patients with UC [5, 6]. Since mitochondria
are the primary source of cellular ATP, this impli-
cates a pathophysiological relevance of mitochondrial
dysfunction.
Mitochondrial dysfunction is commonly caused by sin-
gle nucleotide polymorphism (SNPs) of the mitochon-
drial genome and inadequate repair mechanisms [7].
Monogenic mutations of mitochondrial genes are known
to cause severe mitochondrial dysfunction leading to
rare and multisystemic diseases like Kearns Sayre Syn-
drome, Leigh-syndrome or Leber’s Hereditary Optic
Neuropathy [8–11]. According to the current know-
ledge, these syndromes are not associated with UC.
However, the mitochondrial DNA codes for mitochon-
drial oxidative phosphorylation proteins and conse-
quently may be of high relevance for the cellular energy
supply. Thus, cells with high need of energy to persevere
organ function are highly susceptible to mutations of the
mitochondrial genome. Many cell types of the intestinal
tract, such as epithelial cells, muscle cells, and immune
cell, have high-energy requirements. Accordingly, it is
highly likely that the mitochondrial DNA and respective
variants may be involved in gastrointestinal symptoms.
In fact, gastrointestinal symptoms of irritable bowel syn-
drome could already been linked to mitochondrial poly-
morphisms [12]. Furthermore, there is increasing
evidence for a role of mitochondrial gene polymor-
phisms in the development of common diseases such as
type 2 diabetes mellitus, neurodegenerative diseases and
several different types of cancer [13–16].
We recently described that variants in mitochondrial
DNA determine mucosal ATP levels and susceptibility
to experimental colitis in mice [17]. In addition, in a
small European UC cohort a mitochondrial polymorph-
ism was just recently described to be associated with UC
[18]. However, mitochondrial SNPs are usually excluded
from genetic associations studies, so we aimed at investi-
gating the role of mitochondrial gene variations in the
development of UC. Here, we report on a mitochondria-
wide genetic association study using a large German UC
study group and population-based controls. The restric-
tion to German subjects has the advantage that the Ger-
man population is known to be genetically quite
homogenous [19]. As a result, a male-specific association
between a genetic variation of the MT-ND4 gene (11719
A/G, rs2853495) and UC could be identified and repli-
cated in another independent set of German subjects.
Methods
Study subjects
In total, 2687 German UC patients were available for
this study who were recruited at the Department of
General Internal Medicine of the Christian-Albrechts-
University Kiel, the Charité University Hospital Berlin,
through local outpatient services, and nationwide with
support of the German Crohn and Colitis Foundation.
Of these, 1043 German patients were previously used in
a genome-wide association study (GWAS) for UC [20].
Clinical, radiological, histological, and endoscopic (i.e.
type and distribution of lesions) examinations were re-
quired to unequivocally confirm the diagnosis of UC
[21]. Data from 1062 out of all 2687 UC cases composed
of 459 males and 603 females were used in the initial
study (more characteristics in Additional file 1: Table
S1). Data of the remaining 1625 UC cases composed of
706 males, 914 females and 5 patients with missing sex
were used for replication.
For the initial study 1795 healthy controls were selected
from the KORA F4 survey [22], which is an independent
population-based sample of the general population living
in the region of Augsburg, Southern Germany. In
addition, data from 1240 German control individuals was
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obtained from the Popgen biobank [23] for the initial
study resulting in a total of 3035 controls (1565 males,
1470 females). For the replication study, data from 3575
controls from Popgen biobank composed of 1701 males
and 1874 females were used. Of note, 1214 controls sub-
jects from the Popgen biobank and 489 controls from the
KORA survey, respectively, had been part of the previous
GWAS [20].
Genotyping
Single nucleotide polymorphism (SNP) genotyping in the
discovery panel was performed using the Affymetrix®
Genome-Wide Human SNP Array 6.0 (for details see
[20]). Genotype calling was performed using the Birdseed
v2 algorithm implemented in Affymetrix Power Tools ver-
sion 1.12.0. Prior to genotype calling, samples with a low
contrast-quality control value (contrast-qc < 0.40) were
excluded.
Quality control
For quality control on individual level in the initial study
group we excluded samples with a call fraction < 90 %
for the mitochondrial SNPs. This applied to five control
individuals resulting in data for 1062 UC cases and 3030
controls. On mitochondrial marker level we excluded
SNPs with MAF < 0.5 %. This applied to 60 of the initial
119 SNPs. Nine SNPs were excluded because of a call
fraction < 90 % separate for cases and controls and two
SNPs because they were wrongly assigned to the mito-
chondrial DNA. Furthermore, we investigated the cluster
plots of the remaining mitochondrial SNPs and excluded
21 SNPs with critical issues. In conclusion, 27 mitochon-
drial SNPs passed our quality control. In Europeans 144
variants with a frequency >1 % were identified [13]. 37
out of these 144 variants are captured or partly captured
by our 27 SNPs after quality control.
For quality control on nuclear marker level we ex-
cluded SNPs with MAF < 1 %, call fraction < 98 % separ-
ate for cases and controls and p value < 10−04 for test on
Hardy Weinberg equilibrium in the controls. We also
excluded SNPs on the X or Y chromosome. 546,808 of
the initial 934,968 nuclear SNPs passed our quality
control.
Statistical analysis
Our primary association analysis in the initial study
group was based on testing for associations between sin-
gle SNPs and the UC phenotype by applying Fisher’s
exact test. This was done for the total initial study group
and separate for males and females. The most promising
SNPs from this approach with p value < 0.01 were taken
forward to replication. To analyze joint effects across
both stages, the Cochran Mantel Haenszel test was used.
The global significance level is set to 0.05, which
corresponds to a local significance level of 0.05/(27⋅3) =
6.2⋅10−04 for testing 27 SNPs in three groups.
For secondary association analysis we reconstructed
haplogroups. The haplogroup assignment was conducted
by using the web application HaploGrep [24] that is
based on Phylotree [25]. According to the recommenda-
tions we only included haplogroup assignments with a
quality score above 90 % as determined by HaploGrep.
The only exception was haplogroup H2a2a, whose qual-
ity score was 0 %, because this is the haplogroup of the
reference sequence rCRS. This yielded haplogroup as-
signments with good quality for 1059 cases and 3007
controls. Although HaploGrep gives very specific subha-
plogroups, we only used the corresponding main hap-
logroups that are most common in Europe (H, I, J, K, T,
U, V, W, X, HV, JT) for further analysis. We compared
the relative frequencies of the most common European
haplogroups in our sample to the frequencies given by
Mitomap [26] and found good agreement (Additional
file 2: Table S2). We only included European hap-
logroups with a frequency above 2 % and used Fisher’s
exact test to test each haplogroup against all other hap-
logroups in the total initial study group and separate for
males and females. Haplogroups H, V and HV were ex-
amined as one group named HV because of their close
relationship. Allele counts for all markers in the tested
haplogroups are provided in Additional file 3: Table S3.
The functional relevance of the mitochondrial SNP
rs2853495 may be affected by the nuclear genome. Thus,
to further explore our findings, we tested for an inter-
action between the most promising mitochondrial SNP
rs2853495 and nuclear SNPs in the total initial study
group and the subgroup of males. We used a logistic re-
gression model for each nuclear SNP that included the
main effects of the nuclear and the mitochondrial SNPs
and the interaction term. We modeled additive effects
for the nuclear SNPs and we used a 0, 1 allele dosage
coding for the mitochondrial SNPs. A genome-wide sig-
nificance level of 5⋅10−08 was used for the interaction
analysis.
Software
We used the free software R [27] and Plink [28] for qual-
ity control and analysis.
Results
Table 1 lists SNPs with a p value < 0.01 in the total initial
sample or in one of the sex-specific subgroups. Association
plots for all SNPs in the total initial sample and both sex-
specific subgroups are shown in Additional file 4: Figure S1,
Additional file 5: Figure S2 and Additional file 6: Figure S3.
The association of the SNP rs2853495 in the geneMT-ND4
with UC was successfully validated in the total sample, and
the combined analyses of this SNP across both stages
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yielded a p value of 1.9⋅10−4 (odds ratio (OR), 1.19; 95 %
confidence interval (95 % CI), 1.09 to 1.30). This is signifi-
cant on a global significance level of 0.05, which corre-
sponds to a local significance level of 0.05/(27⋅3) = 6.2⋅10−4
adjusted for testing of 27 mitochondrial SNPs in three
groups. In the sex-specific analyses the association between
rs2853495 and UC was only identified in the subgroup of
males. This was also validated using the male subgroup of
the replication data. The combined analyses across both
stages yielded a significant p value of 1.5⋅10−5 (OR, 1.35;
95 % CI, 1.18 to 1.55). Notably, the p value was smaller in
the subgroup of males even though the sample size was
smaller than in the total initial sample.
The second approach was to test for association be-
tween mitochondrial haplogroups and UC (see Table 2).
The lowest p values in the total sample were reached for
haplogroups HV and T (p = 0.029 and 0.035), in which
haplogroup HV is determined by the mitochondrial
11719 A/G polymorphism. Accordingly, the association
to haplogroup HV was only found in the subgroup of
males (p = 0.009).
No interaction between SNP rs2853495 and a nuclear
SNP reached genome-wide significance, i.e. p < 5⋅10−8, in
the total initial sample but some of the results merit fur-
ther attention. Specifically, a cluster of SNPs on chromo-
some 3 shows interaction with rs2853495 (see Table 3).
The results for the top 50 nuclear SNPs according to the p
value for interaction are shown in Additional file 7: Table
S4. Additional file 8: Table S5 shows the results for all nu-
clear SNPs with interaction p value < 1⋅10−04 in the sub-
group of males.
Discussion
As the salient finding of this study, we identified an associ-
ation between a homoplastic mitochondrial DNA vari-
ation in the gene MT-ND4 (11719 A/G, rs2853495) with
male UC patients. This association was even validated in a
second independent sample, and the combined value is
significant after controlling for the multiple testing of 27
mitochondrial SNPs in three groups.
The here reported mtDNA variation (11719 A/G,
rs2853495) affects the gene MT-ND4, which encodes for
one subunit of the NADH dehydrogenase 4 of complex I
of the mitochondrial respiratory chain. Since this endo-
symbiosis of mitochondria eukaryotic cells, the mito-
chondria have lost most of their genetic material to the
cell nucleus. However, mitochondria still retained some
genes in their own genome, which are highly essential
for cellular respiration and ATP generation [29]. The
gene MT-ND4 encodes for one subunit of the NADH
dehydrogenase 4 as a part of the mitochondrial oxidative
phosphorylation system (OXPHOS) complex I. Complex
I consists of 44 different subunits, seven of which are
mitochondrially encoded [30]. The function of complex
I as first step of the electron transport chain is to extract
electrons from NADH and donate them to ubiquinone.
This reaction releases energy, which is used to transport
protons across the mitochondrial inner membrane. In
this way, complex I contributes to the maintenance of
the proton gradient, which fuels mitochondrial ATP pro-
duction and many other mitochondrial functions [31].
Mutations in the MT-ND4 gene may have an important
influence on mitochondrial respiratory chain function
and therefore a genetic variation of this gene may lead
to alterations of the cellular energy metabolism.
Table 1 Results from the single SNP association analysis for SNPs with a two-sided p value < 0.01 from Fisher’s exact test in the initial
sample or in one of the sex-specific subgroups
mtSNPa BPb A1c A2d Subsample Initial analysis Replication Combinedg
p ORe A1c frequency p ORe A1 frequency p ORe
Cases Ctrlsf Cases Ctrlsf
rs2853495 11719 G A Total 0.007 1.22 [1.06; 1.40] 0.528 0.478 0.011 1.17 [1.04; 1.31] 0.525 0.486 1.921⋅10−4 1.19 [1.09; 1.30]
Males 0.002 1.40 [1.13; 1.73] 0.562 0.479 0.002 1.32 [1.10; 1.57] 0.551 0.482 1.512⋅10−5 1.35 [1.18; 1.55]
Females 0.328 1.10 [0.91; 1.34] 0.502 0.477 – – – – – –
rs3899498 13368 A G Total 0.005 0.71 [0.56; 0.91] 0.085 0.115 0.334 0.90 [0.74; 1.10] 0.091 0.100 1.012⋅10−2 0.82 [0.70; 0.95]
Males 0.126 0.75 [0.53; 1.07] 0.090 0.117 – – – – – –
Females 0.026 0.68 [0.49; 0.96] 0.080 0.113 – – – – – –
aMitochondrial single nucleotide polymorphism; bBase-pair position according to UCSC version hg19; cEffect allele; dSecond allele; eOdds ratio with 95 %
confidence interval; fControls; gCombined analysis of initial and replication data
Table 2 Results of the haplogroup based analysis with
frequencies of cases and controls in the total sample and p
values from Fisher’s exact test
Haplogroup Control Cases pa pmales
b pfemales
c
HV 48.05 52.03 0.029 0.009 0.498
U 15.96 15.30 0.624 0.056 0.322
J 9.94 9.82 0.952 0.060 0.147
T 11.64 9.25 0.035 0.357 0.060
K 7.02 7.08 0.944 1.000 0.929
ap value in the total sample, bp value in the subgroup of males, cp value in the
subgroup of females
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Consequently, a mutation in this mitochondrial gene
may contribute among many other factors to mitochon-
drial dysfunction and mucosal energy deficiency, which
has been detected in UC patients [5, 6].
The here identified DNA variation in MT-ND4 has
been previously shown to be associated with numerous
classical mitochondrial disorders like Leber’s Hereditary
Optic Neuropathy [32] or Leigh syndrome [30]. More-
over, dysfunction of MT-ND4 has been described in the
context of experimental autoimmune encephalomyelitis,
which is an animal model of multiple sclerosis [33],
breast cancer [34], cystic fibrosis [35] and other diseases.
Most interestingly, a recent report in a small cohort of
UC patients could bring a different mitochondrial DNA
variant affecting MT-ND4 into relation to UC, which un-
derlines the possible relevance for intestinal homeostasis
[18]. Of note, we found the association only for male
subjects. In fact, there are several studies reporting UC
to be more frequent in males [1, 36, 37]. Moreover, it
was observed that males responded less to a three
months corticosteroidal therapy in terms of mucosal
healing [38]. Beside these reports, it is well known that
male mice respond aggravated to experimental colitis
[39]. However, it remains speculation whether mito-
chondrial gene polymorphisms may be implicated in
these clinical observations. Therefore, we alternatively
suggest the presence of cofactors functionally cooperat-
ing with the polymorphism of MT-ND4, which increase
the susceptibility for UC. These cofactors could for in-
stance be nuclear encoded genes. Accordingly, we stud-
ied interactions between the identified mitochondrial
SNP and nuclear SNPs. As apparent in Additional file 7:
Table S4 and Additional file 8: Table S5 no genome-wide
significant interaction was found. Nevertheless, interest-
ing candidates emerged from these analyses. These SNPs
merit further investigation due to their involvement in
highly energy-dependent pathways such as Calcium-
dependent secretion activator 1 (CADPS) and the
Vesicle-trafficking protein SEC22A [40, 41]. However,
more detailed data, e.g. provided by deep sequencing,
are necessary to answer the question, whether there are
functionally active interactions between mitochondrial
and nuclear gene variations.
Considering that homoplasmic mitochondrial DNA
variants, like the here identified polymorphism, fre-
quently determine haplogroups [42], we tested for asso-
ciations between different mitochondrial haplogroups
and UC. The lowest p values were reached for the mito-
chondrial haplogroups HV and T (p = 0.029 and 0.035).
Notably, the mitochondrial 11719 A/G polymorphism
signifies the haplogroup HV [43]. Considering that these
haplogroups occur approximately in 40-50 % of modern
Eurasian ethnicity, in which the incidence of IBD is par-
ticularly high [44, 45], these results might further point
to a critical role of the mitochondrial genome for the
pathogenesis of UC. Haplogroup T is additionally de-
fined by a signature SNP of complex I [46, 47]. Hap-
logroup T is currently found with high concentration in
the eastern Baltic Sea region, in which the incidence of
IBD is emerging [45]. Whether this might be a func-
tional connection of mitochondrial haplogroups and UC
or just a coincidence must be investigated in the future.
Conclusions
We identified and replicated a yet unknown male-specific
association between a mitochondrial gene polymorphism
in MT-ND4 (11719 A/G, rs2853495) and UC. This indi-
cates that mitochondrial genetics may determine gender-
specific differences in disease prevalence and therapeutical
response. Consequently, this study may help to deepen
the knowledge of UC pathology and clinical course. Fur-
ther studies are required to recapitulate the association of




BPb A1c p Gene
Nucleard Mitoe Interactionf
3 rs7620175 35155767 T 6.58⋅10−02 4.25⋅10−01 8.47⋅10−06 LOC101928135
rs12493494 60412390 T 1.41⋅10−03 4.37⋅10−06 1.57⋅10−05 FHIT
rs505014 62731917 G 2.12⋅10−04 1.11⋅10−01 5.78⋅10−05 CADPS
rs498746 62731985 T 2.64⋅10−04 1.48⋅10−01 9.26⋅10−05 CADPS
rs4676732 121314320 T 2.74⋅10−02 9.31⋅10−02 6.99⋅10−05 FBXO40
rs6784995 122938098 A 7.04⋅10−04 9.13⋅10−07 3.37⋅10−05 SEC22A
rs9289215 122962809 A 2.72⋅10−03 1.37⋅10−06 8.36⋅10−05 SEC22A
rs6784930 123001494 A 1.76⋅10−02 1.21⋅10−06 1.03⋅10−05 ADCY5
rs17809756 159630084 A 4.30⋅10−06 7.33⋅10−01 7.79⋅10−06 Near SCHIP1, ILI2A
rs6800685 190139275 T 5.61⋅10−02 2.10⋅10−01 1.12⋅10−05 Near CLDN16, TMEM207
aChromosome; bBase-pair position according to UCSC version hg19; cMinor allele; dMain effect of nuclear SNP; eMain effect of mitochondrial SNP; fInteraction term
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mitochondrial gene polymorphisms and UC and to eluci-
date the definite role of the mitochondrial genome in UC
development.
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